Systemic sclerosis (scleroderma)

Adil I. Khan, Joseph Susa, M. Qasim Ansari

Research output: Contribution to journalArticle

Abstract

In summary, systemic sclerosis is a chronic inflammatory disease that can affect both the subcutaneous tissue and viscera. Clinical symptoms due to tissue fibrosis, vascular damage, and the generation of antinuclear antibodies. Laboratory diagnosis requires the detection ANA and anti- Scl-70 antibodies. While the etiology remains unknown, better understanding of the disease, have improved the treatment and overall disease prognosis.

Original languageEnglish (US)
Pages (from-to)723-726
Number of pages4
JournalLaboratory Medicine
Volume36
Issue number11
DOIs
StatePublished - Nov 2005

Fingerprint

Systemic Scleroderma
Viscera
Clinical Laboratory Techniques
Antinuclear Antibodies
Subcutaneous Tissue
Tissue
Blood Vessels
Fibrosis
Chronic Disease
Antibodies

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Pathology and Forensic Medicine

Cite this

Khan, A. I., Susa, J., & Ansari, M. Q. (2005). Systemic sclerosis (scleroderma). Laboratory Medicine, 36(11), 723-726. https://doi.org/10.1309/DQXM-W624-C3RM-84E2

Systemic sclerosis (scleroderma). / Khan, Adil I.; Susa, Joseph; Ansari, M. Qasim.

In: Laboratory Medicine, Vol. 36, No. 11, 11.2005, p. 723-726.

Research output: Contribution to journalArticle

Khan, AI, Susa, J & Ansari, MQ 2005, 'Systemic sclerosis (scleroderma)', Laboratory Medicine, vol. 36, no. 11, pp. 723-726. https://doi.org/10.1309/DQXM-W624-C3RM-84E2
Khan, Adil I. ; Susa, Joseph ; Ansari, M. Qasim. / Systemic sclerosis (scleroderma). In: Laboratory Medicine. 2005 ; Vol. 36, No. 11. pp. 723-726.
@article{46e6030af837474c879d9dbf5ed09998,
title = "Systemic sclerosis (scleroderma)",
abstract = "In summary, systemic sclerosis is a chronic inflammatory disease that can affect both the subcutaneous tissue and viscera. Clinical symptoms due to tissue fibrosis, vascular damage, and the generation of antinuclear antibodies. Laboratory diagnosis requires the detection ANA and anti- Scl-70 antibodies. While the etiology remains unknown, better understanding of the disease, have improved the treatment and overall disease prognosis.",
author = "Khan, {Adil I.} and Joseph Susa and Ansari, {M. Qasim}",
year = "2005",
month = "11",
doi = "10.1309/DQXM-W624-C3RM-84E2",
language = "English (US)",
volume = "36",
pages = "723--726",
journal = "Laboratory Medicine",
issn = "0007-5027",
publisher = "American Society of Clinical Pathologists",
number = "11",

}

TY - JOUR

T1 - Systemic sclerosis (scleroderma)

AU - Khan, Adil I.

AU - Susa, Joseph

AU - Ansari, M. Qasim

PY - 2005/11

Y1 - 2005/11

N2 - In summary, systemic sclerosis is a chronic inflammatory disease that can affect both the subcutaneous tissue and viscera. Clinical symptoms due to tissue fibrosis, vascular damage, and the generation of antinuclear antibodies. Laboratory diagnosis requires the detection ANA and anti- Scl-70 antibodies. While the etiology remains unknown, better understanding of the disease, have improved the treatment and overall disease prognosis.

AB - In summary, systemic sclerosis is a chronic inflammatory disease that can affect both the subcutaneous tissue and viscera. Clinical symptoms due to tissue fibrosis, vascular damage, and the generation of antinuclear antibodies. Laboratory diagnosis requires the detection ANA and anti- Scl-70 antibodies. While the etiology remains unknown, better understanding of the disease, have improved the treatment and overall disease prognosis.

UR - http://www.scopus.com/inward/record.url?scp=27544489438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544489438&partnerID=8YFLogxK

U2 - 10.1309/DQXM-W624-C3RM-84E2

DO - 10.1309/DQXM-W624-C3RM-84E2

M3 - Article

AN - SCOPUS:27544489438

VL - 36

SP - 723

EP - 726

JO - Laboratory Medicine

JF - Laboratory Medicine

SN - 0007-5027

IS - 11

ER -